A two-year, non-ACGME advanced training program at Memorial Sloan Kettering Cancer Center offering intensive clinical and translational research experience in the management of primary and secondary CNS malignancies, including VMAT/IMRT, proton radiotherapy, stereotactic radiosurgery, and intracranial brachytherapy.
Eligibility Criteria:
-
Completed residency in radiation oncology.
-
Eligible for New York medical licensure by the start date.
-
ABR board certification/eligibility (or equivalent); Canadian graduates expected to have passed Royal College qualifying exams.
-
If not a U.S. citizen or permanent resident, eligibility for H1B (requires USMLE Steps 1–3).
-
NYS Controlled Substance Registration (required for clinical duties).
Funding Details:
-
Competitive salary and benefits provided by the institution (details not publicly specified).
-
Financial support available for conference travel related to research presentations.
Deadline:
-
Not specified in the announcement; applications are accepted via the online portal and reviewed on a rolling basis.
Where to go for further information:
- Apply via the MSK online application portal.
- General inquiries: [email protected]